Now let me write the final consolidated review.

## Summary

ProteinVista introduces a 3D CNN architecture that voxelizes full-atom protein structures at 1.0 Å resolution, pre-trains on ~500K AlphaFold-2 structures (using contrastive alignment with ESM-2 or Rosetta regression), and fine-tunes on downstream prediction tasks. The model achieves competitive performance on transporter-substrate classification, enzyme-substrate classification, and IC50 regression while requiring substantially fewer parameters (123M vs 650M) and compute (~1% of ESM-2's GPU-hours for pre-training).

## Strengths

1. **Genuine compute efficiency advantage** (Section 4.3, Fig 3). Pre-training on 4 A100s for 48 hours vs ESM-2's 7 days on 128 H100s is a practically meaningful contribution. The runtime comparison (20s vs 426s per 1K proteins on an A100) is well-documented and striking. This is the paper's strongest concrete achievement.

2. **Honest stratified analysis of when the method helps vs. when it doesn't** (Section 4.1, Fig 2a–d). Partitioning the test set by sequence identity, TM-score, and pLDDT gives a nuanced picture of the model's applicability regime. The GO annotation result (F_max 0.57 vs 0.62 for ESM-2) is presented without spin and the paper acknowledges limitations. This kind of analysis is valuable.

3. **Well-targeted ablation studies** (Section 4.2, Fig 2e). Testing pre-training objective, voxel resolution, augmentation, and ensemble size isolates the contribution of each design choice. The finding that fine-tuning augmentation has essentially no effect (−0.1%) is non-obvious and useful.

4. **Adaptive boxing strategy** (Section 2.1) — choosing among 64³, 96³, 128³, 160³ grids based on protein size — is a practical engineering contribution that directly addresses the sparsity problem that prior work flagged as prohibitive for 3D CNNs on proteins.

## Weaknesses

### Fatal
None.

### Major

1. **The contrastive pre-training objective uses ESM-2 as a teacher, which confounds the central comparison.** Section 2.3 describes a contrastive objective that pulls ProteinVista's embeddings toward ESM-2's sequence embeddings via InfoNCE loss. When the paper then compares the fine-tuned models and claims ProteinVista "outperforms sequence transformers," ProteinVista has been pre-trained to align with the very model it is compared against. The paper never acknowledges this confounding issue or discusses what it means for the independence of the comparison. This is partially mitigated by the ablation showing Rosetta regression (no ESM-2 dependency) gives only a 1% relative R² drop — meaning the model does not entirely depend on ESM-2 distillation — but the paper never makes this argument itself. The headline claim that "structure outperforms sequence" is weakened because the structure model was explicitly trained to mimic the sequence model's representations during pre-training.

2. **The "outperforms" claim is overstated relative to the evidence.** Examining Tables 1 and 2:
   - **TSP**: ProteinVista 90.8% vs ESM-2₆₅₀ₘ 89.3% — +1.5% (real but modest)
   - **ESP**: ProteinVista 91.8% vs ESM-2₆₅₀ₘ 91.9% — slight **loss** (tied, ESM-2 marginally ahead)
   - **IC50**: ProteinVista R² 0.69 vs ESM-2₆₅₀ₘ 0.61 — +0.08 (most meaningful individual result)
   
   The abstract and title claim outperformance across "three benchmarks," but on ESP ProteinVista does not outperform. The gains on individual tasks are modest. No confidence intervals or standard deviations across random seeds are reported, so it is unclear whether the observed differences are within run-to-run variability. The paper's strongest case often relies on the ESM-ProteinVista ensemble, not on ProteinVista alone.

3. **No "no pre-training" baseline is reported.** The ablation compares contrastive vs. Rosetta pre-training (Section 4.2) but never compares against training ProteinVista from scratch on the downstream task. This makes it impossible to separate the value of the architecture from the value of pre-training.

### Minor

4. **Rotation robustness is limited to 90° discrete orientations** (Section 2.4). The data augmentation applies only 90° rotations and mirror reflections, yielding at most 24 discrete orientations from cube symmetry. The introduction uses aspirational language ("aimed to achieve rotation-invariant predictions"), but the paper never tests whether performance degrades under arbitrary rotations (e.g., 45° around any axis). The ablation showing near-zero effect of disabling augmentation during fine-tuning (−0.1%) could alternatively indicate the test set has a consistent orientation convention rather than true rotation invariance.

5. **No confidence intervals or standard deviations across random seeds.** Results are reported throughout as point estimates. For a comparison where the headline gains are 0.2–1.5%, this is essential for assessing significance.

6. **The optimized pipeline (OP, Section 3.3) bundles multiple changes** (updating MolFormer weights, training a contrastive network, ensembling) simultaneously, making it impossible to attribute the SOTA-beating gains to ProteinVista specifically rather than to the more complex pipeline.

7. **The reported Wilcoxon p-value (p < 10⁻³⁰⁴) for the IC50 comparison is extreme.** While mathematically possible with very large sample sizes and log-space computation, such a value is unusual and the paper should explain how it was computed.

### Trivial
None.

## Nice-to-Haves
- Test on arbitrarily rotated test inputs to measure actual rotation robustness beyond 90°.
- Report what fraction of test proteins exceed the 160³-voxel grid and get cropped.
- Consider replacing the contrastive objective with a self-supervised structural objective (e.g., masked voxel prediction) to cleanly separate structural reasoning from ESM-2 distillation, as the Rosetta regression ablation already suggests the model does not depend on ESM-2.

## Removed Points
- "Pre-training with ESM-2 as the teacher undermines the 'outperforms sequence transformers' claim (structural)" — Kept as Major #1 but the harsh critic's characterization as an absolute "structural flaw" that "invalidates" the paper is too strong given the Rosetta regression ablation (1% drop). The criticism is reframed as a major, resolvable issue.
- "The ensemble underperforms ProteinVista alone on IC50" — The paper discusses this openly and the explanation is internally consistent (sequence adds little when structure captures all needed info). Removed.
- "FLOPs vs runtime: some of the gap may come from implementation-specific factors" — Speculative without evidence. Removed.
- "Section 1 para 5 is dismissive of prior work" — Subjective opinion, not a factual error. Removed.
- "The comparison to SPOT and ProSmith-ESP should ideally control for pipeline complexity" — This is what the OP experiment attempts. Merged into Minor #6.
- "Adaptive boxing: what fraction of proteins are cropped?" — Moved to Nice-to-Haves.
- Generic strengths about "important problem" — Removed as superficial.

## Novel Insights

The review reveals that ProteinVista's strongest contribution is not its raw accuracy (which is modest and confounded by the ESM-2 pre-training) but its demonstration of feasibility and compute efficiency for full-atom 3D CNNs at scale. The compute advantage (1% GPU-hours, 20× faster inference) is a genuinely practical contribution that could make structure-based methods viable where they were previously dismissed as too expensive. The paper's most scientifically valuable finding — that the Rosetta regression ablation gives nearly equivalent performance — actually undercuts the headline "outperforms" claim but simultaneously strengthens the architecture's independence from ESM-2. A reframed paper centered on "competitive performance at a fraction of the cost" would be stronger than the current "outperforms" framing.

## Suggestions
1. Replace the contrastive pre-training objective with a self-supervised structural objective (e.g., masked voxel prediction or rotation prediction) and re-evaluate, OR clearly separate two distinct claims: (a) cross-modal distillation from ESM-2 enables transfer, and (b) the architecture itself is viable when pre-trained on structures alone (supported by the Rosetta regression ablation).
2. Add confidence intervals or standard deviations across multiple random seeds for all main results.
3. Add a "training from scratch" (no pre-training) baseline.
4. Tone down the "outperforms" language in the title and abstract to reflect the more nuanced findings (e.g., "competitive with," "compute-efficient alternative to").
5. Test rotation robustness on arbitrarily rotated test inputs.

## Score and Decision

**Round 1 Bracket**: After initial calibration, the plausible score range was [3.5, 6.0].

**Calibration Anchors** (all rounds):
| Paper | Path | Avg Score | Round | Comparison |
|-------|------|-----------|-------|------------|
| ProteiNexus | iBAWiEjogY.md | 3.67 | R1 | Similar topic (protein structure pre-training). Weaker than ProteinVista — had data leakage concerns and less clear contribution. |
| 3D Mol Pretraining (LEGO) | rEQ8OiBxbZ.md | 3.00 | R1 | Molecular 3D pretraining. Weaker than ProteinVista — unconvincing experiments and limited evidence. |
| AtomSurf | ARQIJXFcTH.md | 6.75 | R1 | Protein surface representation. Stronger than ProteinVista — better experimental rigor on Atom3D benchmark, clearer contributions. |
| ProteinAdapter | jqx5XI4Yr3.md | 3.40 | R1 | Adapting protein models. Weaker — limited novelty. |
| E^3former | QKywN4BbqA.md | 5.25 | R1 | Protein representation learning with structure. Similar quality — mixed reviews (6,6,6,3), rejected due to insufficient novelty. |
| EquiPocket | umUIYdLtvh.md | 5.50 | R2 | Binding site prediction with GNN. Similar quality — well-executed but limited significance; rejected. |
| Seq/Struct/Surface Pretraining | BEH4mGo7zP.md | 5.75 | R2 | Multimodal protein pretraining. Slightly stronger — first to use surface; accepted despite marginal gains. |
| Protein-ligand binding repr | AXbN2qMNiW.md | 5.67 | R2 | Binding representation learning. Slightly stronger — clearer framing; accepted. |

**Calibration Reasoning**: ProteinVista has a clearer engineering contribution (compute efficiency, adaptive boxing) than ProteiNexus (3.67) or LEGO (3.00), placing it above those. However, it has a more significant methodological confound (ESM-2 pre-training) than AtomSurf (6.75), EquiPocket (5.50), or the Seq/Struct/Surface paper (5.75), which all have cleaner experimental designs. The ESM-2 pre-training issue and the overstated claims bring it below the borderline accept range (~6). A score of 5.0 reflects that the paper has real contributions (compute efficiency, honest analysis, practical engineering) but the central claim is undermined by the pre-training design and the performance gains are modest. With major revisions — particularly replacing the contrastive pre-training or significantly reframing the claims — this could become a strong paper.

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>